Company: RENEF
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001104659-25-111663
Chunk: 8

Company: Cartesian Growth Corp II
Filing Date: 2025-11-14
Form: 10-Q
Item: Part II, Item 2U
Chunk 8
---
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On May 10, 2022, we consummated the initial public offering of 23,000,000 units, including the full exercise by underwriters of their over-allotment option, at a purchase price of $10.00 per unit, generating total gross proceeds of $230,000,000. The securities sold in our initial public offering were registered under the Securities Act on registration statement on Form S-1 (File No. 333-261866). The registration statement became effective on March 5, 2022.

A total of $236,900,000 of the net proceeds from the initial public offering, the sale of the private placement warrants and the sponsor loan was deposited in a trust account established for the benefit of our public shareholders, with Continental Stock Transfer & Trust Company acting as trustee. Following redemptions in connection with the First and Second Charter Amendments, as of November 7, 2024, there was a total of $83,770,196.61 remaining in the trust account. As of September 30, 2025, there was a total of $88,478,622 in the trust account. Following redemptions in connection with the Third Charter Amendment, as of November 4, 2025, there was a total of $37,750,814.08 remaining in the trust account. For a description of the use of the proceeds generated in the initial public offering, see Part I, Item 2 of this Quarterly Report.